BioSkryb Genomics
PrivateLast Round
Series A
May 1, 2025
Total Funding Raised
$31.5M
Company Overview
BioSkryb Genomics is a biotechnology company that develops a genome amplification system leveraging cellular heterogeneity to provide scientists and clinicians with comprehensive insights into the genome, transcriptome, and proteome of individual cells for the study of complex diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioSkryb Genomics Comparables
Compare BioSkryb Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mission Bio | 83% | |
| Xingeyuan Biotechnology | 79% | |
| Atrandi Biosciences | 79% | |
BioSkryb Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 1, 2025 | ||||
| Seed | Jan 9, 2020 |
Key People
Founding team and executive leadership
BioSkryb Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Anzu Partners | Series A, Seed |
| Wilson Sonsini Goodrich & Rosati | Seed, Series A |
| Seed Healthcare | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 7, 2025
Partnered with Eremid Genomic Services for new ResolveSEQ LongRead solution.
- Oct 7, 2025
Launched ResolveSEQ LongRead solution with Eremid Genomic Services.
BioSkryb Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioSkryb Genomics's valuation, stock price, and market status.